Propellon Therapeutics has a total of 38 patents globally, out of which 13 have been granted. Of these 38 patents, more than 47% patents are active. Japan is where Propellon Therapeutics has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and Canada is the origin country of Propellon Therapeutics.
Propellon Therapeutics founded in 2016, Propellon Therapeutics is a biotechnology company developing innovative cancer therapies targeting the WDR5 protein. WDR5 plays a critical role in methyltransferase complex formation and histone modification, with its overexpression linked to various cancers and poor patient outcomes. Propellon’s inhibitor platform is based on research from the Ontario Institute for Cancer Research (OICR), aiming to advance next-generation epigenetic treatments.
Do read about some of the most popular patents of Propellon Therapeutics which have been covered by us in this article and also you can find Propellon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Propellon Therapeutics patent portfolio.
How many patents does Propellon Therapeutics have?
Propellon Therapeutics has a total of 38 patents globally. These patents belong to 3 unique patent families. Out of 38 patents, 18 patents are active.
How Many Patents did Propellon Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Propellon Therapeutics Applications Filed | Propellon Therapeutics Patents Granted |
| 2025 | – | 2 |
| 2024 | 1 | – |
| 2022 | 2 | 7 |
| 2021 | – | 4 |
| 2020 | 1 | – |
| 2019 | 1 | – |
| 2018 | 12 | – |
| 2017 | 21 | – |
How many Propellon Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Propellon Therapeutics File in Different Countries?
Countries in which Propellon Therapeutics Filed Patents
| Country | Patents |
| Japan | 5 |
| United States of America | 4 |
| Europe (EPO) | 3 |
| Australia | 3 |
| Canada | 3 |
| China | 2 |
| Mexico | 2 |
| Denmark | 1 |
| Israel | 1 |
| Austria | 1 |
| South Africa | 1 |
| Germany | 1 |
| Eurasia | 1 |
| Hong Kong (S.A.R.) | 1 |
| India | 1 |
| Chile | 1 |
| Brazil | 1 |
| Colombia | 1 |
| Ecuador | 1 |
| Korea (South) | 1 |
Where are Research Centres of Propellon Therapeutics Patents Located?
All Research centers of Propellon Therapeutics are in the United States of America.
Best Patent of Propellon Therapeutics
WO2017147700A1 is the most popular patent in the Propellon Therapeutics portfolio. It has received 43 citations so far from company like Daiichi Sankyo, and Huyabio International.
Below is the list of most cited patents of Propellon Therapeutics:
| Publication Number | Citation Count |
| WO2017147700A1 | 43 |
| WO2017147701A1 | 23 |
| US20200385371A1 | 7 |
| JP2020532561A | 5 |
| WO2019046944A1 | 5 |
| US11174250B2 | 2 |
| CN111372926A | 2 |
| US11319299B2 | 1 |
List of Propellon Therapeutics Patents
| Propellon Therapeutics Patents | Title |
| US12264147B2 | Substituted Carboxamides As Inhibitors Of Wdr5 Protein-Protein Binding |
| JP7624690B2 | Inhibitors Of Wdr5 Protein-Protein Binding |
| JP2024102151A | Inhibitors Of Wdr5 Protein-Protein Binding |
| US11319299B2 | Substituted Carboxamides As Inhibitors Of Wdr5 Protein-Protein Binding |
| EP3423451B1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| CN109195965B | Inhibitors Of Wdr5 Protein-Protein Binding |
| DK3423451T3 | Inhibitors Of Wdr5 Protein-Protein Binding |
| DE602017060763T2 | Inhibitors Of Wdr5 Protein-Protein Binding |
| AT1512102T | Inhibitoren Der Wdr5-Protein-Proteinbindung |
| IL261472B | Inhibitors Of Wdr5 Protein-Protein Binding |
| JP2022071046A | Inhibitor Of Wdr5 Protein-Protein Binding |
| US11174250B2 | Substituted Carboxamides As Inhibitors Of Wdr5 Protein-Protein Binding |
| ZA201805879B | Inhibitors Of Wdr5 Protein-Protein Binding |
| AU2017226004B2 | Inhibitors Of Wdr5 Protein-Protein Binding |
| EA038109B1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| EP3679031A4 | Inhibitors Of Wdr5 Protein-Protein Binding |
| US20200385371A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| CN111372926A | Inhibitors Of Wdr5 Protein-Protein Binding |
| MX2020002399A | Inhibitors Of Wdr5 Protein-Protein Binding. |
| HK40001696A | Inhibitors Of Wdr5 Protein-Protein Binding |
| AU2018328768A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| JP2020532561A | Inhibitor Of Wdr5 Protein-Protein Binding |
| JP2019507179A5 | Inhibitor Of Wdr5 Protein-Protein Binding |
| EP3423437A4 | Inhibitors Of Wdr5 Protein-Protein Binding |
| WO2019046944A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| MX2018010374A | Inhibitors Of Wdr5 Protein-Protein Binding. |
| CA3073977A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| IN201817035913A | Inhibitors Of Wdr5 Protein-Protein Binding |
| CL201802505A1 | Compounds Derived From Substituted 4-Fluorophenyl-Acetamide, Wdr5 Inhibitors; Pharmaceutical Composition That Includes Them And Their Use In The Treatment Of Cancer. |
| BR112018067392A2 | Wdr5 Protein Binding Inhibitors |
| CO20180010504A2 | Wdr5 Protein-Protein Binding Inhibitors |
| ECSP18073726A | Wdr5 Protein-Protein Bonding Inhibitors |
| AU2017226005A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| KR1020180120720A | Inhibitors Of Wdr5 Protein-Protein Binding |
| WO2017147700A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| WO2017147701A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| CA3015406A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
| CA3015417A1 | Inhibitors Of Wdr5 Protein-Protein Binding |
What are Propellon Therapeutics key innovation segments?
What Technologies are Covered by Propellon Therapeutics?
The chart below distributes patents filed by Propellon Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Propellon Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Propellon Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Propellon Therapeutics?
